The results indicated that DHZCP inhibits colorectal cancer liver metastasis, likely associated with blocking CCL2/CCR2 activation in the liver and suppressing the CCL2-mediated M2-skewing paradigm. This evidence concerns the gene CCR2 and colorectal cancer.